NLRP3 and Parkinson disease: Despite the fact that itaconate has been reported to benefit multiple inflammatory diseases through the inhibition of NLRP3 inflammasome, we demonstrate the potential of itaconate in treating PD and its relation to modulating the NLRP3 inflammasome in PD for the first time.